MedPath

Prednisone

Generic Name
Prednisone
Brand Names
Deltasone, Rayos, Winpred
Drug Type
Small Molecule
Chemical Formula
C21H26O5
CAS Number
53-03-2
Unique Ingredient Identifier
VB0R961HZT

Overview

A synthetic anti-inflammatory glucocorticoid derived from cortisone. It is biologically inert and converted to prednisolone in the liver. Prednisone was granted FDA approval on 21 February 1955.

Background

A synthetic anti-inflammatory glucocorticoid derived from cortisone. It is biologically inert and converted to prednisolone in the liver. Prednisone was granted FDA approval on 21 February 1955.

Indication

Prednisone is indicated as an anti-inflammatory or immunosuppressive drug for allergic, dermatologic, gastrointestinal, hematologic, ophthalmologic, nervous system, renal, respiratory, rheumatologic, infectious, endocrine, or neoplastic conditions as well as in organ transplant.

Associated Conditions

  • Acne Vulgaris
  • Acute Exacerbation of Chronic Obstructive Pulmonary Disease
  • Acute Gouty Arthritis
  • Acute Leukemia
  • Aggressive Lymphoma
  • Allergic Bronchopulmonary Aspergillosis
  • Allergic Conjunctivitis (AC)
  • Allergic Rhinitis (AR)
  • Allergic corneal marginal ulcers
  • Alveolitis, Extrinsic Allergic
  • Ankylosing Spondylitis (AS)
  • Aspiration Pneumonitis
  • Asthma
  • Atopic Dermatitis
  • Autoimmune Hepatitis
  • Bell's Palsy
  • Berylliosis
  • Bullous dermatitis herpetiformis
  • Chorioretinitis
  • Congenital Adrenal Hyperplasia (CAH)
  • Congenital Hypoplastic Anemia
  • Contact Dermatitis
  • Disseminated tuberculosis
  • Drug hypersensitivity reaction
  • Edema of the cerebrum
  • Epicondylitis
  • Erythroblastopenia
  • Giant Cell Arteritis (GCA)
  • Hypercalcemia of Malignancy
  • Idiopathic Pulmonary Fibrosis (IPF)
  • Immune Thrombocytopenia (ITP)
  • Iridocyclitis
  • Iritis
  • Keratitis
  • Leukemias
  • Loeffler's syndrome
  • Lymphoma
  • Meningitis caused by Mycobacterium Tuberculosis
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • Mycosis Fungoides (MF)
  • Ocular Inflammation
  • Ophthalmia, Sympathetic
  • Optic Neuritis
  • Pain caused by Herpes zoster
  • Pemphigus
  • Pericarditis
  • Pneumocystis Jirovecii Pneumonia
  • Polymyalgia Rheumatica (PMR)
  • Polymyositis
  • Posterior Uveitis
  • Primary adrenocortical insufficiency
  • Psoriatic Arthritis
  • Pure Red Cell Aplasia
  • Regional Enteritis
  • Relapsing Polychondritis
  • Rheumatoid Arthritis
  • Rheumatoid Arthritis, Juvenile
  • Secondary adrenocortical insufficiency
  • Secondary thrombocytopenia
  • Serum Sickness
  • Severe Seborrheic Dermatitis
  • Sjogren's Syndrome (SS)
  • Solid Organ Transplant Rejection
  • Stevens-Johnson Syndrome
  • Systemic Lupus Erythematosus
  • Takayasu Arteritis
  • Thyroid Eye Disease
  • Thyroiditis
  • Thyrotoxicosis
  • Trichinosis
  • Ulcerative Colitis
  • Uveitis
  • Vasculitis
  • Acquired immune hemolytic anemia
  • Acute Bursitis
  • Acute Crohn's Disease (CD)
  • Acute Multiple sclerosis exacerbation
  • Acute rheumatic carditis
  • Anterior eye segment inflammation
  • Exfoliative erythroderma
  • Fulminating Tuberculosis
  • Idiopathic Bronchiolitis obliterans with organizing pneumonia
  • Idiopathic eosinophilic pneumonias
  • Non-suppurative Thyroiditis
  • Severe Psoriasis
  • Subacute Bursitis
  • Symptomatic Sarcoidosis
  • Synovitis of osteoarthritis
  • Systemic Dermatomyositis
  • Varicella-zoster virus acute retinal necrosis

Clinical Trials

View More Clinical Trials

Sign in to access the complete clinical trial database with detailed study information.

Title
Posted
Study ID
Phase
Status
Sponsor
2009/10/02
Phase 3
Completed
2009/09/30
Phase 4
Completed
2009/09/24
Phase 2
Withdrawn
2009/09/11
Phase 4
Completed
University Hospital, Basel, Switzerland
2009/09/09
Phase 3
Completed
University Hospital, Basel, Switzerland
2009/09/09
Phase 2
Completed
2009/09/07
Phase 1
Active, not recruiting
2009/09/07
Phase 2
UNKNOWN
2009/08/11
Not Applicable
UNKNOWN
Health Science Center of Xi'an Jiaotong University
2009/07/24
Phase 2
Completed

FDA Drug Approvals

View More FDA Approvals

Sign in to access additional FDA-approved drug information with detailed regulatory data.

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

View More EMA Approvals

Sign in to access additional EMA-approved drug information with detailed regulatory data.

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

View More HSA Approvals

Sign in to access additional HSA-approved drug information with detailed regulatory data.

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

View More NMPA Approvals

Sign in to access additional NMPA-approved drug information with detailed regulatory data.

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

View More PPB Approvals

Sign in to access additional PPB-approved drug information with detailed regulatory data.

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

View More TGA Approvals

Sign in to access additional TGA-approved drug information with detailed regulatory data.

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath